MMP2 and MMP3 Polymorphisms and Melanoma Progression
Author Information
Author(s): Cotignola Javier, Roy Pampa, Patel Ami, Ishill Nicole, Shah Shivang, Houghton Alan, Coit Daniel, Halpern Allan, Busam Klaus, Berwick Marianne, Orlow Irene
Primary Institution: Memorial Sloan-Kettering Cancer Center
Hypothesis
Do functional polymorphisms in MMP2 and MMP3 genes affect melanoma progression?
Conclusion
The study found no significant evidence linking MMP2 and MMP3 genetic variants to melanoma progression.
Supporting Evidence
- No significant associations were found after adjusting for known melanoma confounders.
- A new G to A variation in the MMP2 promoter was identified but its functional consequence is unclear.
- The study included a diverse cohort of melanoma patients with various stages of the disease.
Takeaway
The researchers looked at specific genes to see if they affect melanoma, but they didn't find any strong links.
Methodology
The study evaluated MMP2 and MMP3 germline polymorphisms in melanoma patients using PCR-based methods and various statistical tests.
Limitations
The associations lost significance after adjusting for confounders like age, sex, and race.
Participant Demographics
95% were cutaneous malignant melanoma patients, predominantly Caucasian (96%), with ages ranging from 5 to 89 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website